期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Treatment of eosinophlic esophagitis with swallowed topical corticosteroids 被引量:1
1
作者 Simon Nennstiel Christoph Schlag 《World Journal of Gastroenterology》 SCIE CAS 2020年第36期5395-5407,共13页
Eosinophilic esophagitis(EoE)is an emerging chronic local immune-mediated disease of the esophagus.Beside proton pump inhibitors and food-restrictiondiets swallowed topical corticosteroids(STC)can be offered as a firs... Eosinophilic esophagitis(EoE)is an emerging chronic local immune-mediated disease of the esophagus.Beside proton pump inhibitors and food-restrictiondiets swallowed topical corticosteroids(STC)can be offered as a first line therapy according to current guidelines.This review describes the background and practical management of STCs in EoE.So far,mainly asthma inhalers containing either budesonide or fluticasone have been administered to the esophagus by swallowing these medications“off label”.Recently esophagus-targeted formulations of topical steroids have been developed showing clinicopathological response rates up to 85%-an orodispersible tablet of budesonide has been approved as the first“in label”medication for EoE in Europe in June 2018.Whereas it was shown that disease remission induction of EoE by STCs is highly effective,there is still a lack of data regarding long-term and maintenance therapy.However,current studies on STC maintenance therapy add some movement into the game. 展开更多
关键词 Eosinophilic esophagitis Swallowed topical corticosteroids Esophagustargeted formulations of topical steroids FLUTICASONE BUDESONIDE Budesonide orodispersible tablet Budesonide oral suspension
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部